Feedback / Questions
2X-121 - Oncology Venture
LiPlaCis (liposomal cisplatin) - Oncology Venture
dovitinib (TKI258)
http://www.globenewswire.com/news-release/2019/04/30/1812516/0/en/Oncology-Venture-prolongs-subscription-period.html
Apr 30, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next